243 related articles for article (PubMed ID: 25454243)
21. Arsenic exposure in US public and domestic drinking water supplies: a comparative risk assessment.
Kumar A; Adak P; Gurian PL; Lockwood JR
J Expo Sci Environ Epidemiol; 2010 May; 20(3):245-54. PubMed ID: 19401722
[TBL] [Abstract][Full Text] [Related]
22. Increased lung cancer risks are similar whether arsenic is ingested or inhaled.
Smith AH; Ercumen A; Yuan Y; Steinmaus CM
J Expo Sci Environ Epidemiol; 2009 May; 19(4):343-8. PubMed ID: 19190673
[TBL] [Abstract][Full Text] [Related]
23. Development of a cancer-based chronic inhalation reference value for hexavalent chromium based on a nonlinear-threshold carcinogenic assessment.
Haney JT; Erraguntla N; Sielken RL; Valdez-Flores C
Regul Toxicol Pharmacol; 2012 Dec; 64(3):466-80. PubMed ID: 23103602
[TBL] [Abstract][Full Text] [Related]
24. An overview of human exposure modeling activities at the USEPA's National Exposure Research Laboratory.
Furtaw EJ
Toxicol Ind Health; 2001 Jun; 17(5-10):302-14. PubMed ID: 12539877
[TBL] [Abstract][Full Text] [Related]
25. A comparison of several measures of exposure to arsenic. Matched case-control study of copper smelter employees.
Lee-Feldstein A
Am J Epidemiol; 1989 Jan; 129(1):112-24. PubMed ID: 2910055
[TBL] [Abstract][Full Text] [Related]
26. Extended Analysis and Evidence Integration of Chloroprene as a Human Carcinogen.
Sax SN; Gentry PR; Van Landingham C; Clewell HJ; Mundt KA
Risk Anal; 2020 Feb; 40(2):294-318. PubMed ID: 31524302
[TBL] [Abstract][Full Text] [Related]
27. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
28. Inhalation cancer risk assessment of cobalt metal.
Suh M; Thompson CM; Brorby GP; Mittal L; Proctor DM
Regul Toxicol Pharmacol; 2016 Aug; 79():74-82. PubMed ID: 27177823
[TBL] [Abstract][Full Text] [Related]
29. Arsenic and respiratory cancer in humans: follow-up of copper smelter employees in Montana.
Lee-Feldstein A
J Natl Cancer Inst; 1983 Apr; 70(4):601-10. PubMed ID: 6572748
[TBL] [Abstract][Full Text] [Related]
30. Lung cancer mortality at a UK tin smelter.
Jones SR; Atkin P; Holroyd C; Lutman E; Batlle JV; Wakeford R; Walker P
Occup Med (Lond); 2007 Jun; 57(4):238-45. PubMed ID: 17437956
[TBL] [Abstract][Full Text] [Related]
31. Development of linear and threshold no significant risk levels for inhalation exposure to titanium dioxide using systematic review and mode of action considerations.
Thompson CM; Suh M; Mittal L; Wikoff DS; Welsh B; Proctor DM
Regul Toxicol Pharmacol; 2016 Oct; 80():60-70. PubMed ID: 27233922
[TBL] [Abstract][Full Text] [Related]
32. US EPA's IRIS pilot program: establishing IRIS as a centralized, peer-reviewed data base with agency consensus. Integrated Risk Information System.
Mills A; Foureman GL
Toxicology; 1998 May; 127(1-3):85-95. PubMed ID: 9699796
[TBL] [Abstract][Full Text] [Related]
33. Bayesian benchmark dose analysis for inorganic arsenic in drinking water associated with bladder and lung cancer using epidemiological data.
Shao K; Zhou Z; Xun P; Cohen SM
Toxicology; 2021 May; 455():152752. PubMed ID: 33741492
[TBL] [Abstract][Full Text] [Related]
34. Arsenic exposure and bladder cancer: quantitative assessment of studies in human populations to detect risks at low doses.
Tsuji JS; Alexander DD; Perez V; Mink PJ
Toxicology; 2014 Mar; 317():17-30. PubMed ID: 24462659
[TBL] [Abstract][Full Text] [Related]
35. Contribution of metals to respiratory cancer.
Peters JM; Thomas D; Falk H; Oberdörster G; Smith TJ
Environ Health Perspect; 1986 Dec; 70():71-83. PubMed ID: 3830115
[TBL] [Abstract][Full Text] [Related]
36. Inorganic arsenic--ambient level approach to the control of occupational cancerigenic exposures.
Blejer HP; Wagner W
Ann N Y Acad Sci; 1976; 271():179-86. PubMed ID: 1069501
[TBL] [Abstract][Full Text] [Related]
37. Mortality experience in relation to a measured arsenic trioxide exposure.
Pinto SS; Enterline PE; Henderson V; Varner MO
Environ Health Perspect; 1977 Aug; 19():127-30. PubMed ID: 908288
[TBL] [Abstract][Full Text] [Related]
38. Development of a unit risk factor for 1,3-butadiene based on an updated carcinogenic toxicity assessment.
Grant RL; Haney J; Curry AL; Honeycutt M
Risk Anal; 2009 Dec; 29(12):1726-42. PubMed ID: 19878488
[TBL] [Abstract][Full Text] [Related]
39. Concentrations, sources and human health risk of inhalation exposure to air toxics in Edmonton, Canada.
Bari MA; Kindzierski WB
Chemosphere; 2017 Apr; 173():160-171. PubMed ID: 28110005
[TBL] [Abstract][Full Text] [Related]
40. Personal exposure meets risk assessment: a comparison of measured and modeled exposures and risks in an urban community.
Payne-Sturges DC; Burke TA; Breysse P; Diener-West M; Buckley TJ
Environ Health Perspect; 2004 Apr; 112(5):589-98. PubMed ID: 15064166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
